Molecular genetic features of hereditary forms of breast cancer (systematic review)

Author:

Serebryakova A. V.1ORCID,Aliyev K. A.1ORCID,Sorokina L. E.2ORCID,Gritskevich O. Yu.1ORCID,Zyablitskaya E. Yu.1ORCID

Affiliation:

1. Institute «Medical Academy named after S.I. Georgievsky» V.I. Vernadsky Crimean Federal University

2. Institute «Medical Academy named after S.I. Georgievsky» V.I. Vernadsky Crimean Federal University; National Research Center ― Institute of Immunology Federal Medical-Biological Agency of Russia

Abstract

The interest in the problem of hereditary forms of breast cancer is due not only to the increase in the number of patients, but also to the existing features in relation to the phenotypic characteristics of these tumors, course features, and sensitivity to various therapy options. Unfortunately, the data of clinical trials that exist to date do not provide a complete picture of the course of various forms of hereditary breast cancer, sensitivity to therapeutic agents, adequate examination volumes and preventive measures. In this regard, there is a need to conduct prospective randomized trials to optimize treatment, screening and prevention programs. The rapid development of technologies in the field of molecular biology has made it possible to identify about 20 genes, the presence of mutations in which causes an increased risk of developing breast cancer. The aim of this review was to summarize the available data on the role of structural rearrangements of genes of varying degrees of penetrance associated with hereditary predisposition to breast cancer. The mechanism of hereditary breast cancer forms development is associated with rearrangements in DNA repair genes of varying degrees of penetrance. The identification of these mutations is of strategic importance for early diagnosis and the transition from an empirical to a targeted personalized approach in the treatment of various types of cancer. Understanding the pathogenesis of the disease at the molecular level makes it possible to make a breakthrough in the field of pharmacological innovations in order to create new selective classes of drugs in effective targeted therapy.

Publisher

Publishing House OKI

Subject

General Medicine

Reference83 articles.

1. Zlokachestvennye novoobrazovaniya v Rossii v 2020 g. (zabolevaemost' i smertnost') /pod red. A.D. Kaprina, V.V. Starinskogo, A.O. Shakhzadovoi. M.: MNIOI im. P.A. Gertsena — filial FGBU «NMITs radiologii» Minzdrava Rossii, 2021. [Malignant tumors in Russiain 2020 (morbidity and mortality) /Ed by. AD Kaprina, VV Starinskogo, GV Petrovoi. Moscow: P.A. Herzen MSIOI — filial of NMRC of radiology Ministry of Public Health of the Russian Federation, 2021 (In Russ.)].

2. World Health Organization. The Global Cancer Observatory (vklyuchaya bazu dannykh GLOBOCAN 2018). Geneva: WHO; 2021.

3. Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. NY: Garland Science; 2012. p. 1205-1268.

4. Bit-Sava E.M., Belogurova M.B. Nasledstvennyi rak molochnoi zhelezy. Sibirskii onkologicheskii zhurnal. 2013;55(1):75–81. [Bit-Sava EM, Belogurova NB. Hereditary breast cancer. Siberian journal of oncology. 2013;55(1):75–81. (In Russ.)].

5. European Society for Medical Oncology. BRCA in breast cancer: ESMO Clinical Recommendations. 2018.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3